Lipum Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Ola Sandborgh

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	less than a year
Proprietà del CEO	0.2%
Durata media del management	less than a year
Durata media del Consiglio di amministrazione	3.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Ola Sandborgh (58 yo)

less than a year

Mandato

Mr. Ola Sandborgh serves as CEO at Lipum AB (publ) since November 09, 2023. He has experience from the pharmaceutical industry where he has worked in leading roles in different commercial, innovation and b...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Olle Hernell	Co-Founder & Director	no data	SEK 347.00k	1.61% SEK 5.8m
Marina Norberg	Chief Financial Officer	3.8yrs	SEK 716.76k	0.077% SEK 278.7k
Ola Sandborgh	Chief Executive Officer	less than a year	Nessun dato	0.18% SEK 641.2k
Susanne Lindquist	Co-Founder & Head of Research (CSO)	no data	Nessun dato	1.53% SEK 5.6m
Pernilla Abrahamsson	Chief Operating Officer	no data	Nessun dato	0.034% SEK 121.8k
Peter Hovstadius	Chief Medical Officer	less than a year	Nessun dato	Nessun dato

1.0yrs

Durata media

61yo

Età media

Gestione esperta: Il team dirigenziale di LIPUM non è considerato esperto (durata media 1 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Olle Hernell	Co-Founder & Director	no data	SEK 347.00k	1.61% SEK 5.8m
Gustav Kihlstrom	Independent Chairman of the Board	3.4yrs	Nessun dato	Nessun dato
Björn Löwenadler	Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
Carl-Johan Spak	Independent Director	1.5yrs	Nessun dato	0.017% SEK 59.9k
Anders Fasth	Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
Lennart Lundberg	Member of Scientific Advisory Board	3.3yrs	Nessun dato	Nessun dato
Asa Hansdotter	Independent Director	3.4yrs	Nessun dato	Nessun dato
Kristian Sandberg	Independent Director	4.7yrs	Nessun dato	Nessun dato
Rikard Holmdahl	Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
Solbritt Dahlqvist	Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
Asa Magnusson	Director	less than a year	Nessun dato	Nessun dato

3.4yrs

Durata media

69.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di LIPUM sono considerati esperti (durata media dell'incarico 3.4 anni).

Lipum Gestione

Gestione criteri di controllo 1/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Lipum AB (Publ) Welcomes Peter Hovstadius as Chief Medical Officer

High number of new directors

Lipum AB (publ) Announces Nomination Committee Appointments

Lipum AB (Publ) Appoints Ola Sandborgh as Chief Executive Officer, Effective from December 1, 2023

Lipum AB (Publ) Appoints Karin Franck-Larsson as CMO

Lipum Elects Carl-Johan Spak as New Board Member

Recent updates

Lipum AB (publ) to Report Q3, 2024 Results on Oct 25, 2024

Lipum AB (publ) to Report Fiscal Year 2024 Results on Feb 26, 2025

New minor risk - Share price stability

Lipum AB (Publ) Welcomes Peter Hovstadius as Chief Medical Officer

New major risk - Financial position

High number of new directors

Lipum AB (publ) Completes Multiple Dose Part of the Phase I Clinical Study

Lipum AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 79.714945 million.

Lipum Recommends Shareholders to Not Accept Mandatory Cash Offer

Lipum Recommends Shareholders to Not Accept Mandatory Cash Offer

Forecast to breakeven in 2025

Lipum AB (publ) has filed a Follow-on Equity Offering.

Lipum AB (publ) has filed a Follow-on Equity Offering.

Lipum AB (publ) Reports Positive Interim Results from Clinical Phase 1 Study Showing that SOL-116 Reduces Plasma BSSL Levels in Healthy Subjects

Lipum AB (Publ) Receives Funding from Vinnova for an Eurostars Application

Lipum AB (publ) Announces Nomination Committee Appointments

Lipum AB (Publ) Appoints Ola Sandborgh as Chief Executive Officer, Effective from December 1, 2023

New major risk - Revenue and earnings growth

Lipum AB (Publ) Appoints Karin Franck-Larsson as CMO

New minor risk - Share price stability

New major risk - Revenue and earnings growth

Lipum Elects Carl-Johan Spak as New Board Member

Chief Executive Officer recently bought kr161k worth of stock

Lipum AB (publ) Announces the Nomination Committee for the 2023 Annual General Meeting

Chief Executive Officer recently bought kr157k worth of stock

Lipum AB (Publ) Has Initiated A Phase 1 Clinical Study with Its Drug Candidate Sol-116

Lipum AB (publ) announced that it has received SEK 38.999963 million in funding from Flerie Invest AB

Lipum AB (publ) Gets Approval to Start Phase 1 Clinical Trial with Drug Candidate Sol-116

Lipum AB (publ) Appoints Helena Bergström as Chief Medical Officer

Lipum Reports Completion of GLP Toxicology- and Safety Program on the Candidate Drug (SOL-116)

Chief Executive Officer recently bought kr195k worth of stock

Lipum AB (Publ) Reports Gmp Production of Sol-116 Successful

Lipum Recruits Fredrik Seijsing as Scientist

Lipum AB (publ) Initiates GMP-Production for Clinical Trials

Lipum Is At the Final Step Before Clinical Phase

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media